IVRN — Innoveren Scientific Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $5.58m
- $0.45m
Annual cashflow statement for Innoveren Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.39 | -29.8 | -6.46 | -4.8 | -10.3 |
| Depreciation | |||||
| Non-Cash Items | 0.607 | 16.8 | -0.693 | 0.733 | 7.91 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.148 | -0.098 | -0.187 | -0.759 | 0.464 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.54 | -12.3 | -7.26 | -4.81 | -1.91 |
| Capital Expenditures | -0.023 | -0.021 | -0.002 | -0.008 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | -0.372 | 0 | — | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.023 | -0.393 | -0.002 | -0.008 | 0 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.39 | 14 | 7.48 | 3.27 | 1.82 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.182 | 1.35 | 0.217 | -1.55 | -0.095 |